ePrints

Recommendations to support deprescribing medications late in life

Lookup NU author(s): Professor Adam ToddORCiD

Downloads

Full text for this publication is not currently held within this repository. Alternative links are provided below where available.

Abstract

It is widely acknowledged that patients-particularly those late in life-are frequently exposed to the harms of medication. To minimize these harms, several frameworks have been developed by which prescribing can be optimized. In the context of diminishing life expectancy, these frameworks can be used to reduce medications that are no longer necessary, but appear to fall short of actual guidelines that incorporate a consideration of stopping medications. In this commentary, we present recommendations that could be incorporated into prescribing processes for all healthcare professionals and, ultimately, used to support the rationalization or deprescribing of medication in diminished life expectancy. We frame these recommendations in the same context as guidance for the initiation and discontinuation of implantable cardiac devices and argue that the two processes-with regards to decision-making-should be the same. We present our recommendations with preventive medication use in mind, and use statin therapy as an illustrative example.

Publication metadata

Author(s): Todd A, Holmes HM

Publication type: Article

Publication status: Published

Journal: International Journal of Clinical Pharmacy

Year: 2015

Volume: 37

Issue: 5

Pages: 678-681

Print publication date: 01/10/2015

Online publication date: 16/06/2015

Acceptance date: 01/01/1900

ISSN (print): 2210-7703

ISSN (electronic): 2210-7711

Publisher: Springer

URL: https://doi.org/10.1007/s11096-015-0148-6

DOI: 10.1007/s11096-015-0148-6

PubMed id: 26078120

Altmetrics

Share